FDA Infant Formula Regulations 2026: Proposed Nutrient Updates, Chemical Contaminant Testing And Compliance Requirements

What the FDA’s Latest Infant Formula Actions Mean for Manufacturers, Importers, Suppliers and Food Regulatory Compliance

The US Food and Drug Administration (FDA) is advancing new initiatives to strengthen infant formula safety, nutritional standards and regulatory oversight through two important actions announced on 29 October 2026.

As part of the Trump Administration’s Operation Stork Speed initiative, the FDA has introduced:

• A proposed rule on infant formula nutrient requirements: Revisions to certain existing nutrient specifications, measurement units and labelling requirements.
• New chemical contaminant testing results: Publication of testing data indicating that most infant formula samples tested contained low or non-detectable levels of chemical contaminants.

These developments represent an important step towards modernizing US infant formula standards while strengthening transparency around chemical contaminant monitoring.

The proposed rule forms part of the FDA's first comprehensive review of infant formula nutrient requirements since 1998. Meanwhile, the testing programme provides additional information about potential contaminants, including heavy metals, PFAS, pesticides and plasticizers.

These developments are particularly relevant to infant formula manufacturers, ingredient suppliers, importers, contract manufacturers, distributors and regulatory affairs professionals operating in the US market.

Why the FDA's Infant Formula Regulatory Updates Matter

Infant formulas are an important source of nutrition for babies who rely on formula exclusively or alongside breastfeeding.

Ensuring appropriate nutritional composition and controlling potential chemical contaminants are essential considerations for manufacturers and regulatory authorities.

The FDA's latest actions address two interconnected regulatory priorities:

1. Nutritional adequacy: Reviewing existing nutrient specifications to ensure they reflect current scientific evidence and infant nutritional requirements.
2. Chemical safety: Monitoring contaminants that may enter infant formula through ingredients, water, agricultural sources and manufacturing processes.

For manufacturers, these developments highlight the importance of strengthening:

• Nutrient formulation and product development.
• Ingredient qualifications and sourcing.
• Chemical contaminant testing.
• Supplier quality management.
• Product safety assessments.
• Regulatory documentation and labelling.
• Manufacturing quality control.
• Regulatory monitoring and change management.

What Is the FDA's Two Infant Formula Actions in 2026?

The FDA announced two separate initiatives under its broader Operation Stork Speed programme.

The proposed rule is not yet final. Manufacturers should monitor the rulemaking process and evaluate potential impacts rather than treating the proposed specifications as current mandatory requirements.

FDA Proposed Rule: Infant Formula Nutrient Requirements

The FDA's proposed rule represents the first phase of a comprehensive review covering the 30 nutrients currently required in infant formula marketed in the United States.

The proposal focuses on eight nutrients, including revisions to four nutrient requirements and reaffirmation of the existing specifications for four others.

The objective is to ensure that infant formula provides adequate nutrition to support growth and development while avoiding excessive nutrient intake that could create health concerns.

Key Proposed Nutrient Changes

Additional Nutrients Under FDA Review

The FDA is also requesting public input regarding potential requirements for nutrients that are commonly added to infant formula but are not currently mandatory.

These include:

• Arachidonic acid (ARA).
• Docosahexaenoic acid (DHA).
• L-carnitine.

These nutrients are considered as part of the agency's broader assessment of infant nutritional needs and scientific evidence.

Importantly, the current proposed rule does not introduce mandatory requirements for these additional nutrients.

FDA Chemical Contaminant Testing Results: What Did the Data Show?

Alongside the proposed nutrient rule, the FDA released results from its 2023–2025 market basket survey.

The agency tested 312 infant formula samples covering 16 brands, including powdered, concentrated liquid and ready-to-feed products.

The testing programme examined several categories of chemical contaminants to understand potential exposure through infant formula.

Contaminants Included in the Testing Programme

The FDA reported that most samples had undetectable or very low contaminant levels. However, some results prompted additional follow-up activities and continued monitoring.

Important Findings from Heavy Metal Testing

The published testing results provide useful information about the levels of certain toxic elements detected in the samples.

These results are reported for formula prepared for feeding. Non-detection means the concentration was below the analytical method's detection capability; it does not establish absolute absence.

Understanding the FDA's Testing Approach

The FDA uses market basket surveys to examine products representative of infant formula commonly available in the US market.

Samples are purchased from retail outlets and analyzed using specialized methods developed and validated for food matrices, including infant formula.

The agency highlights several important considerations:

• Testing results represent products available at a particular point in time.
• Market basket surveys do not capture every variation between production lots.
• Detection of a contaminant does not automatically mean that a product is unsafe.
• Further testing and risk management activities remain necessary.
• Ingredient sourcing and manufacturing processes may contribute to contaminant levels.

The FDA is also working towards establishing action levels for certain contaminants in infant formula under its broader Closer to Zero initiative.

Who Should Pay Attention to the FDA's Infant Formula Updates?

Regulatory developments may affect businesses throughout the infant nutrition supply chain.

2026–2027 Infant Formula Compliance Readiness Checklist

Companies should begin reviewing their existing compliance programmed to prepare for potential regulatory changes.

Important Regulatory Timeline and Next Steps

The proposed nutrient rule was announced on 29 October 2026 and published in the Federal Register on 2 November 2026.

The proposed rule anticipates that the consolidated final requirements would become effective 60 days after publication in the Federal Register, with a proposed industry compliance period of three years from that effective date.

These are proposed timelines, not currently established implementation deadlines.

Impact on Infant Formula Manufacturers and Importers

The proposed changes could influence product formulation, analytical testing, manufacturing processes and labelling strategies.

Manufacturers should consider:

• Reviewing existing nutrient specifications.
• Evaluating potential formulation adjustments.
• Assessing vitamin, A and vitamin D measurement conversions.
• Reviewing ingredient sources and nutrient contributions.
• Strengthening chemical contaminant testing programmed.
• Evaluating supplier quality agreements.
• Assessing potential labelling updates.
• Preparing technical documentation for future regulatory changes.

Importers and international infant formula businesses should also assess whether their existing products and manufacturing controls are aligned with US regulatory expectations.

Attention should be given to supplier transparency, contaminant testing and traceability across the ingredient supply chain.

Frequently Asked Questions

1. What are the FDA's infant formula regulatory updates in 2026?

The FDA announced a proposed rule to update infant formula nutrient requirements and released new chemical contaminant testing results.

2. Which nutrients are covered by the proposed rule?

Iodine, manganese, vitamin A, vitamin D, chloride, potassium, selenium and sodium.

3. Is the proposed nutrient rule already mandatory?

No. It is a proposed rule and must undergo the regulatory rulemaking process before becoming final.

4. What contaminants did the FDA test for?

The testing included arsenic, cadmium, lead, mercury, 30 PFAS, 318 pesticides, phthalates and a non-phthalate plasticizer.

5. How many infant formula samples were tested?

The FDA tested 312 samples covering 16 brands during its 2023–2025 market basket survey.

6. Were most infant formula samples found to contain contaminants?

Most samples had low or non-detectable levels. However, some findings required additional follow-up and monitoring.

7. Does non-detection mean that infant formulas are completely contaminant-free?

No. non-detection means the concentration was below the detection capability of the analytical method.

8. When is the deadline for submitting comments?

The Federal Register specifies 2 March 2027 as the deadline for public comments on the proposed rule.

9. Will manufacturers need to reformulate infant formula?

Potentially. If the proposed changes are finalized, manufacturers may need to adjust formulations and labelling to meet the final specifications.

10. What should infant formula manufacturers do now?

They should review nutrient specifications, ingredient quality, contaminant testing, supplier documentation and potential formulation changes.

Conclusion

The FDA's 2026 infant formula initiatives represent an important development in US food safety and infant nutrition regulation.

The proposed nutrient rule aims to modernize existing nutritional requirements using updated scientific evidence, while the chemical contaminant testing programme strengthens transparency and ongoing product surveillance.

For manufacturers, importers and ingredient suppliers, these developments highlight the importance of proactive regulatory monitoring, robust quality management, ingredient assessments and reliable analytical testing.

Businesses should begin evaluating their existing formulations, supplier controls and contaminant monitoring programmers while following the FDA's proposed rule and subsequent regulatory developments.

Early preparation can help companies manage potential reformulation requirements, strengthen product quality and maintain regulatory readiness in the US infant formula market.

How Maven Regulatory Solutions Can Help

Maven Regulatory Solutions supports food and infant nutrition businesses with:

• US food and infant formula regulatory assessments.
• FDA regulatory compliance reviews.
• Infant formula ingredient assessments.
• Nutritional composition and formulation reviews.
• Chemical contaminant risk assessments.
• Toxicological risk assessments.
• Supplier qualification and compliance assessments.
• Product safety and quality documentation.
• Regulatory labelling assessments.
• Regulatory gap assessments.
• Regulatory intelligence and monitoring.
• Product lifecycle compliance support.

Our approach helps businesses identify regulatory gaps, evaluate ingredient and formulation risks, strengthen quality documentation and prepare for evolving global food regulatory requirements.